Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Auto Physical Damage
News Release
Aviva Canada Selects Mitchell Solutions to Help Streamline Claims Management
SAN DIEGO, Calif.— Mitchell, an Enlyte company and leading technology and information provider for the
Workers' Comp
White Paper
Unlocking the DME “Black Box”
Mitchell
News Release
CDC Updates and Replaces Guidelines for Prescribing Opioids
The Centers for Disease Control and Prevention (CDC) released an updated and expanded recommendation for clinicians prescribing opioids for outpati
PRIMA
Article
The Impact of Resilience on Recovery from Injury or Illness
Read now
Workers' Comp
Article
Ask The Pharmacist: Traveling With a Controlled Substance Prescription Medication
Are there rules or recommendations for traveling with a controlled substance? If a patient is traveling with a controlled substance
Mitchell
Podcast
Trends in Third Party Claims and How to Address Them
Tom Kerr (TK): Enlyte recently released our annual tr